| Symbol: | 
  	  
	  LILRB2
	   | 
      
	  
      
  	  | Description: | 
  	  
	  
	  leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 [Source:HGNC Symbol;Acc:6606]
	  
	   | 
      
      
  	  | Location: | 
  	  
	  Chr19:54777675-54785039[-]
	   | 
      
	  
         
	   
       | CRmiRSNP:
	   
		
	   ~ Export ~
	    
	    | 
      	
      	
      		Records:null
      		 
      			
      			
      				| Compound | 
					CRmiRSNP | 
					SNP_sig | 
					Model | 
					Molecule | 
					Mol_sig | 
					Type | 
      			 
      			
      			
      		 	
      		
      		
      			Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant 
				Total:0 Current:1 
      			[First] [Prev] [Next] [Last] 
      		 
      	 | 
      
	  
	  
	  
       | Compound:
	    
		
	    ~ Export ~
	   
		
	    | 
	  
      	
      	
      		Records:230			
      		 
      			
      				| Gene | 
					Compound | 
      				Gen_sig | 
					Exp_pattern | 
      			 
      		    
      			
      			
				    | LILRB2 | 
					NSC 722388 | 
      				0.01 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					4-[4-(2-Diethylamino-ethylamino)-naphthalen-1-ylazo]-benzene sulfonamide | 
      				0.049 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					NSC 722876 | 
      				0.001 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					NSC 722985 | 
      				0.011 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					NSC 723378 | 
      				0.044 | 
      				Up | 
      			 
      				
      			
      			
				    | LILRB2 | 
					NSC 723548 | 
      				0.034 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					Pyridone-OCH3 | 
      				0.001 | 
      				Up | 
      			 
      				
      			
      			
				    | LILRB2 | 
					(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane | 
      				0.02 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) | 
      				0.007 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					NSC 726373 | 
      				0.031 | 
      				Up | 
      			 
      				
      			
      			
				    | LILRB2 | 
					NSC 726881 | 
      				0.049 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt | 
      				0.036 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					Dasatinib | 
      				0.004 | 
      				Up | 
      			 
      				
      			
      			
				    | LILRB2 | 
					NSC 732719 | 
      				0.004 | 
      				Down | 
      			 
      				
      			
      			
				    | LILRB2 | 
					gamma-glutamyl-alpha-amino-beta-[[2-ethyl(5-fluoro-2'deoxyur idyl) N-methyl-N-(4-chlorobutyl)phosphoramidoyl]sulfonyl] propionyl-(R)-(-)-phenylglycine | 
      				0.039 | 
      				Down | 
      			 
      					
      		 
			
			 Expression pattern: Sensitivity / Resistance 
      			Total:16 Current:14 
      			 First Prev Next Last 
      		  	
      	 | 
      
	   
	  
       | SNP:
	   
		
	    ~ Export ~
	   
	    | 
      	
      	
      		Records:20
      		 	
			
      			Total:2 Current:1 
      			[First] [Prev]  Next Last 
      		  		
      	 | 
      
	  
	  
	  
       | miRNA:
	   
		
	    ~ Export ~
	    
	    | 
      	
      	
      		Records:35
      		 
			
      			Total:3 Current:1 
      			[First] [Prev]  Next Last 
      		  		
      	 |